Cardiovascular Flashcards
Treatment of abdominal aortic aneurysm’s
Patients with large aneurysms –5.5 cm or larger should undergo surgical repair
Two calculations to use in determining the need for anticoagulation in Afib and assessing the bleeding risks
CHA2DS2VASc don’t treat in men of 0 and women score of 1, in general treat males with 2 or higher and females with 3 or higher. HAS-BLED score 3 or higher is risky and can use DOAC score as well.
Best treatment for elevated triglycerides, elevation is levels between 150 and 500. Over 500 equals severely elevated triglycerides
Lose 5% body weight
Lowering carbohydrates especially refined carbohydrates. Increasing fats especially omega-3 fatty acids and increasing protein.
Exercise
Add statin if intermediate risk or greater
Add fibrates if TG >500
What are the levels of 10 yr ASCVD risk, using the calculator
Low is <5%
Borderline is 5-7.5%
Intermediate is 7.5-19.9%
High is >20%
Primary prevention with statins. When to use them. What doses.
Patients with a 10 year risk ASCVD 12% or greater should be on moderate intensity Statin for adults over 40 years old, patients between 6 and 12% should have shared decision making.
Secondary prevention patient should be at least on moderate intensity Statin titrating up to high intensity. Patients with LDL cholesterol 190 or greater should also consider treatment in spite of their 12 year risk factor
How do PCSK9 Inhibitors like repatha and Praluent work
They inhibit PCSK9 action that absorbs and reduces the LDL-R on cell surface of hepatocyte. Thereby increasing the LDL-R and clearing more LDL from blood stream.
What is the cardiac defect in Marfan syndrome
Aortic insufficiency 80–100% of these lead to aortic root dilation
Mitral valve prolapse
Who needs an ABI
anyone >65, Age 50-64 with CAD, Tob use, DM, HLD, HTN, FH of PAD, Age <50 with DM and one other risk factor. (obese, HTN, Tob, HLD, CAD)
grading and staging of heart failure
Grade A,B,C,D
Grade A risks
Grade B structural changes no sxs
Grade C Structural and sxs
Grade D Advanced sxs, impactful, refractory to tx
for Grade C-D
NYHA Stage I,II,III, IV (functional Status)
Describe EF% and how to describe?
Characterization by left ventricular ejection fraction (LVEF) is primarily relevant in stages C and D. Therapy can be tailored by LVEF ranges.
LVEF of 50% or more is classified as preserved.
LVEF of 41% to 49% is classified as mildly reduced. Most patients in this range have a different ejection fraction at the next evaluation.
LVEF of 40% or less is classified as reduced.
LVEF that has improved from 40% or less to greater than 40% is classified as improved.
Tx options for pt for different stages
Stage A (no symptoms): SGLT-2
Stage B (Pre HF): ACE / ARB, Pts with hx of MI or ACS should be on Beta Blocker
Stage C:
Tx of Heart Failure:
When to test and what to check for suspected Heart Failure?
watch for signs of orthopnea, SOB, Edema, SOB with bending down,
Test EKG, BNP, Chest Xray, If concerning order an ECHO
ASCVD risk factors
HTN, HLD, DM, CKD, Tob Use, Obesity, Fam Hx of HLD, Fam Hx of CVD
who should have a 10 year CVD risk assessment?
who should be treated with statin?
who should start aspirin thereapy?
Pts 40-75,
Pts with lifetime risk of >39% should be treated aggressively statins
depends, 10 yr risk >20% or lifetime risk >39% probably yes